![]() |
市場調查報告書
商品編碼
1918331
生物聚合物市場-2026-2031年預測Biopolymers Market - Forecast from 2026 to 2031 |
||||||
預計生物聚合物市場將維持 9.01% 的複合年成長率,從 2025 年的 160.46 億美元成長到 2031 年的 269.27 億美元。
生物聚合物是由玉米、甘蔗、木材和木材廢棄物等可再生生物來源製成的聚合物。與傳統的石油基塑膠不同,生物聚合物可生物分解,從而減少了其對環境污染和全球暖化的影響。隨著各行各業和消費者對永續性重視,生物聚合物在包裝、生物醫學、製藥和食品等眾多領域的應用正在加速成長。對環保塑膠,特別聚羥基烷酯(PHA)的塑膠的需求正在成長,主要的包裝和塑膠製造商正在積極響應終端用戶的需求,提供可生物分解的替代品。在醫療領域,PHA因其對各種類型損傷的優異創傷治療性能而備受青睞。消費者對碳足跡和傳統塑膠危害(例如化學物質滲入食品和飲料)的意識提升不斷提高,進一步推動了人們對更安全、更天然材料的偏好。
市場成長的關鍵促進因素反映了環境、監管和社會壓力的綜合作用。人們對傳統塑膠有害影響的認知不斷提高,推動了對生物聚合物的需求轉變。生物聚合物來自天然物質,因此不會造成毒性暴露的風險。企業和消費者對更健康、更環保產品的需求進一步促進了市場成長。
世界各國政府的嚴格監管是推動這一趨勢的主要因素。諸如禁止使用一次性塑膠製品和推廣天然包裝替代品等舉措旨在遏制廢棄物堆積,隨著人們對石化塑膠的生態危害認知不斷加深,預計這一監管趨勢還將繼續。
消費者對生物分解性塑膠偏好的轉變也是推動此成長的因素之一。生物聚合物在微生物的作用下能夠迅速分解,並且比不可生物分解的材料更快地重新融入自然系統。人們對永續性意識的不斷提高也進一步推動了對這類材料的需求。
醫療產業的成長也將成為另一個驅動力。生物聚合物在關節重建、心臟瓣膜、動脈、牙科零件、肌腱、韌帶和人工水晶體等醫療設備中至關重要,它們能夠修復或替換受損組織。醫療技術的進步和人口老化正在推動醫療設備產業的發展,從而導致對生物聚合物的需求不斷成長。
從細分市場來看,包裝應用這一終端用戶領域預計將佔據主導地位。包裝是生物聚合物的主要用途,能夠保護產品在儲存和運輸過程中免受損壞和污染。食品飲料、醫藥和消費品產業的快速普及,推動了生物聚合物的市場主導地位,而這又得益於消費者購買力的提升、人口成長以及電子商務的興起。此外,環境問題、監管要求以及消費者對可再生資源取代石油基塑膠的需求,也加速了生物聚合物的普及,因為生物聚合物具有污染更少、分解速度更快的優勢。
從區域來看,亞太地區預計將佔據顯著的市場佔有率並呈現強勁成長。這一主導地位歸功於對永續材料日益成長的需求、不斷增強的環保意識以及政府對生物基產品的支持政策。中國、日本和印度是主要的消費國,推動了包括包裝、紡織、汽車和建築在內的眾多產業的應用。該地區豐富的農業資源,特別是甘蔗和玉米,提供了永續的原料來源,而中國、泰國和馬來西亞等國的大規模生產能力則為其提供了有力支撐。
我們的旗艦產品以性能和永續性的創新為特點。
Embalio 的 STANYL® B-MB 是一種 100% 生物基、物料平衡的高溫聚醯胺樹脂,在維持與化石基同類產品相同性能和特性的同時,可減少高達 50% 的碳足跡。本產品已獲得 ISCC+ 認證,可在不影響工程性能的前提下,助力您實現永續性目標。
NatureWorks Ingeo® 生物聚合物 2003D 是一種透明的通用型擠出級熱塑性塑膠,由每年可再生資源製成。此高分子量塑膠專為生鮮食品包裝和餐具而設計,可單獨使用或與其他材料混合使用,並可在標準設備上輕鬆加工。
近期趨勢表明,生物聚合物的功能性持續提高。
2023年4月,NatureWorks推出了Ingeo 6500D,這是一款專為衛生用品領域最佳化的不織布布。結合先進的親水整理技術,它顯著提升了產品的柔軟度、強度和液體管理性能。 Ingeo 6500D經認證為可再生、低碳且生物基材料,滿足了產業和消費者對永續材料日益成長的需求。
受傳統塑膠監管日益嚴格、消費者主導永續性以及包裝和醫療保健產業成長的推動,生物聚合物市場預計將持續擴張。亞太地區的資源優勢和政策支持鞏固了其領先地位。隨著人們對傳統塑膠健康和環境風險的認知不斷提高,生物聚合物正成為向循環經濟轉型的重要推動力,它不僅性能與傳統塑膠相當,而且對環境的影響顯著降低。為了充分利用這一向生物基材料的模式轉移轉變,產業相關人員應優先考慮原料多樣化、符合認證標準以及針對特定應用的創新。
企業使用我們的報告的目的是什麼?
產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報
Biopolymers Market, sustaining a 9.01% CAGR, is anticipated to rise from USD 16.046 billion in 2025 to USD 26.927 billion in 2031.
Biopolymers are polymers produced from renewable biological feedstocks such as corn, sugarcane, timber, and wood waste. Unlike conventional petroleum-derived plastics, biopolymers are biodegradable, mitigating environmental pollution and contributions to global warming. Their adoption is accelerating as industries and consumers prioritize sustainability, with applications spanning packaging, biomedical, pharmaceutical, and food sectors. Heightened demand stems particularly from polyhydroxyalkanoates (PHA)-based eco-friendly plastics, as major packaging and plastics manufacturers respond to end-user requirements for biodegradable alternatives. In biomedical applications, biopolymers are valued for superior wound-healing properties across diverse injury types. Growing consumer awareness of carbon footprints and the hazards of traditional plastics-such as chemical leaching into food and beverages-further drives preference for these safer, natural-origin materials.
Key market growth drivers reflect converging environmental, regulatory, and societal pressures. Increasing recognition of conventional plastics' detrimental impacts is shifting demand toward biopolymers, which pose no risk of toxic exposure due to their natural composition. Enterprises and consumers alike seek healthier, lower-impact options, amplifying market momentum.
Stringent governmental regulations worldwide are a major catalyst. Initiatives banning single-use plastics and promoting natural packaging alternatives aim to curb waste accumulation, with this regulatory trend expected to persist amid greater acknowledgment of petrochemical plastics' ecological harm.
Shifting consumer preferences for biodegradable plastics reinforce expansion. Biopolymers degrade rapidly via microbial action, reintegrating into natural systems far quicker than non-biodegradable counterparts. Heightened sustainability awareness is channeling more demand toward these materials.
Healthcare sector growth provides additional impetus. Biopolymers are integral to medical devices-including joint replacements, heart valves, arteries, dental components, tendons, ligaments, and ocular lenses-facilitating repair or replacement of damaged tissues. Advancements in medical technology and aging demographics are propelling the medical device industry, consequently elevating biopolymer requirements.
From a segmental perspective, the packaging end-user category is projected to dominate market share. Packaging represents the primary application for biopolymers, safeguarding products against damage and contamination during storage and distribution. Surging utilization in food and beverage, pharmaceutical, and consumer goods sectors-driven by rising purchasing power, population growth, and e-commerce proliferation-underpins this leadership. Environmental concerns, regulatory mandates, and consumer demand for renewable-sourced alternatives over petroleum-based plastics further accelerate adoption, as biopolymers offer reduced pollution and faster degradation.
Geographically, Asia Pacific is anticipated to command a substantial market portion and exhibit robust growth. This dominance arises from escalating demand for sustainable materials, mounting environmental consciousness, and supportive government policies favoring bio-based products. Major consumers include China, Japan, and India, where applications span packaging, textiles, automotive, and construction. The region's abundant agricultural resources-particularly sugarcane and corn-provide sustainable feedstocks, complemented by significant production capacities in countries like China, Thailand, and Malaysia.
Leading product offerings highlight innovations in performance and sustainability.
Envalior's STANYL(R) B-MB is a 100% bio-based, mass-balanced high-temperature polyamide that achieves up to a 50% reduced carbon footprint while retaining identical performance, features, and quality to its fossil-based counterpart. ISCC+-certified, it supports customer sustainability goals without compromising engineering properties.
NatureWorks' Ingeo biopolymer 2003D is a transparent, general-purpose extrusion-grade thermoplastic resin derived from annually renewable resources. Specifically formulated for fresh food packaging and serviceware, this high molecular weight grade processes easily on standard equipment, either standalone or in blends.
Recent developments underscore ongoing enhancements in biopolymer functionality.
In April 2023, NatureWorks introduced Ingeo 6500D, a grade optimized for nonwovens in hygiene applications. When combined with advanced hydrophilic finishes, it delivers improved softness, strength, and fluid management. Certified as renewably sourced, low-carbon, and biobased, Ingeo 6500D addresses escalating industry and consumer demands for sustainable material options.
The biopolymers market is poised for sustained expansion, propelled by regulatory enforcement against conventional plastics, consumer-driven sustainability preferences, and sectoral growth in packaging and healthcare. Asia Pacific's resource advantages and policy support solidify its vanguard position. As awareness of traditional plastics' health and environmental risks intensifies, biopolymers emerge as a critical enabler of circular economy transitions, offering comparable performance with markedly lower ecological impact. Industry stakeholders should prioritize feedstock diversification, certification compliance, and application-specific innovations to capitalize on this shifting paradigm toward bio-based materials.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence